Martin Fan
Stock Analyst at Wedbush
(4.49)
# 1,140
Out of 5,189 analysts
88
Total ratings
36.4%
Success rate
23.2%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Martin Fan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IMUX Immunic | Maintained: Buy | $45 | $6.99 | +543.78% | 4 | Nov 18, 2026 | |
| ACRS Aclaris Therapeutics | Downgraded: Hold | $8 → $3 | $3.44 | -12.79% | 9 | Nov 17, 2026 | |
| TRXB TRex Bio | Reiterated: Buy | $30 | $10.32 | +190.84% | 2 | Nov 16, 2026 | |
| TSX: EPRX Eupraxia Pharmaceuticals Inc. | Reiterated: Buy | $24.32 | $8.34 | +191.63% | 3 | Nov 16, 2026 | |
| NKTR Nektar Therapeutics | Reiterated: Hold | $50 → $40 | $30.20 | +32.45% | 6 | Nov 13, 2026 | |
| ZURA Zura Bio | Reiterated: Buy | $22 → $10 | $0.9305 | +974.69% | 6 | Nov 9, 2026 | |
| FATE Fate Therapeutics | Reiterated: Buy | $7 | $0.919 | +661.70% | 8 | Nov 6, 2026 | |
| RNAC Cartesian Therapeutics | Reiterated: Buy | $38 | $6.14 | +518.89% | 8 | Nov 6, 2026 | |
| SANA Sana Biotechnology | Reiterated: Buy | $7 | $1.59 | +340.25% | 6 | Nov 6, 2026 | |
| ZBIO Zenas BioPharma | Reiterated: Buy | $45 | $23.85 | +88.68% | 8 | Nov 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 | $41.64 | +68.11% | 6 | Nov 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $40 → $4 | $3.78 | +5.82% | 4 | Oct 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $165 | $95.81 | +72.22% | 7 | Oct 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $18 → $27 | $19.19 | +40.70% | 4 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $2 | $3.92 | -48.98% | 4 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $46 | $46.13 | -0.28% | 1 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 → $45 | $46.63 | n/a | 2 | Aug 7, 2025 |
Immunic
Nov 18, 2026
Maintained: Buy
Price Target: $45
Current: $6.99
Upside: +543.78%
Aclaris Therapeutics
Nov 17, 2026
Downgraded: Hold
Price Target: $8 → $3
Current: $3.44
Upside: -12.79%
TRex Bio
Nov 16, 2026
Reiterated: Buy
Price Target: $30
Current: $10.32
Upside: +190.84%
Eupraxia Pharmaceuticals Inc.
Nov 16, 2026
Reiterated: Buy
Price Target: $24.32
Current: $8.34
Upside: +191.63%
Nektar Therapeutics
Nov 13, 2026
Reiterated: Hold
Price Target: $50 → $40
Current: $30.20
Upside: +32.45%
Zura Bio
Nov 9, 2026
Reiterated: Buy
Price Target: $22 → $10
Current: $0.9305
Upside: +974.69%
Fate Therapeutics
Nov 6, 2026
Reiterated: Buy
Price Target: $7
Current: $0.919
Upside: +661.70%
Cartesian Therapeutics
Nov 6, 2026
Reiterated: Buy
Price Target: $38
Current: $6.14
Upside: +518.89%
Sana Biotechnology
Nov 6, 2026
Reiterated: Buy
Price Target: $7
Current: $1.59
Upside: +340.25%
Zenas BioPharma
Nov 6, 2026
Reiterated: Buy
Price Target: $45
Current: $23.85
Upside: +88.68%
Nov 4, 2026
Reiterated: Buy
Price Target: $70
Current: $41.64
Upside: +68.11%
Oct 27, 2026
Downgraded: Hold
Price Target: $40 → $4
Current: $3.78
Upside: +5.82%
Oct 27, 2026
Reiterated: Buy
Price Target: $165
Current: $95.81
Upside: +72.22%
Aug 12, 2026
Reiterated: Hold
Price Target: $18 → $27
Current: $19.19
Upside: +40.70%
Aug 6, 2026
Reiterated: Sell
Price Target: $2
Current: $3.92
Upside: -48.98%
Feb 26, 2026
Reiterated: Buy
Price Target: $46
Current: $46.13
Upside: -0.28%
Aug 7, 2025
Reiterated: Buy
Price Target: $40 → $45
Current: $46.63
Upside: n/a